This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Rosetta Genomics Ltd (ROSG)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 16.77M 30.80M 735.00K 2.73M
Receivables 434.00K 163.00K 309.00K 51.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 301.00K 17.00K 0.00
Total Current Assets 25.00M 31.75M 1.21M 3.79M
Property, Plant & Equipment, Gross 2.90M 2.26M 2.30M 2.78M
Accumulated Depreciation & Depletion 2.03M 1.72M 1.71M 1.56M
Property, Plant & Equipment, Net 874.00K 546.00K 592.00K 1.22M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 8.00K 231.00K 242.00K 281.00K
Total Non-Current Assets 882.00K 777.00K 834.00K 1.50M
Liabilities & Shareholder Equity
Total Assets 25.88M 32.53M 2.04M 5.29M
Accounts Payable 906.00K 754.00K 1.85M 1.15M
Short Term Debt 0.00 0.00 0.00 49.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 1.94M 1.27M 1.85M 3.32M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 309.00K 364.00K 552.00K 2.60M
Minority Interest 0.00 0.00 0.00 -387.00K
Total Non-Current Liabilities 309.00K 364.00K 552.00K 3.40M
Total Liabilities 2.25M 1.63M 2.40M 6.72M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 23.63M 30.90M -356.00K -1.43M
Common Par 1.61M 1.38M 108.00K 46.00K
Additional Paid In Capital 130.42M 125.02M 84.58M 74.73M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -108.40M -95.50M -85.04M -76.22M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 7.00K
Total Capitalization 23.63M 30.90M -356.00K -1.43M
Total Equity 23.63M 30.90M -356.00K -1.43M
Total Liabilities & Stock Equity 25.88M 32.53M 2.04M 5.29M
Total Common Shares Outstanding 10.47M 9.10M 701.24K 323.42K
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 3.26K 3.26K 14.00 54.00
Basic Weighted Shares Outstanding 9.59M 4.45M 507.62K 281.80K
Diluted Weighted Shares Outstanding 9.59M 4.45M 507.62K 281.80K
Number of Employees 45 28 22 54
Number of Part-Time Employees 0 0 0 0

ROSG Rosetta Genomics Ltd

Analysts Ratings for ROSG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ROSG Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs